Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+ 

March 31, 2020  |  Startland News Staff

A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.

The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.

“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”

Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.

Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.

Solus Gold Embolization Device

The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.

The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.

Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.

Click here to learn more about these peripheral vascular solutions.

“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”

Tagged , , , ,
Featured Business
    Featured Founder
      [adinserter block="4"]

      2020 Startups to Watch

        stats here

        Related Posts on Startland News

        Roz audits its path to $2.15M in early funding; how KC helped this AI startup scale its potential

        By Tommy Felts | September 18, 2025

        A series of funding wins is boosting a Kansas City startup’s efforts to automate the most complex — and tedious — parts of compliance work, drawing from the co-founder’s own pain points and resources from a server-full of local entrepreneur support initiatives.  With $2.15 million in funding under its belt so far, Olathe-based Roz — which…

        KC GIFT launches ‘Vibe the City’ passport to showcase Black-owned arts, entertainment venues

        By Tommy Felts | September 18, 2025

        A newly published mini-guide to Black-owned arts and entertainment venues across Kansas City is expected to push community members deeper into the metro’s rich Black business ecosystem, said Brandon Calloway, highlighting a range of cultural and nightlife destinations.   “Vibe the City” passports are available now at the G.I.F.T. Business Center at 5008 Prospect Ave.,…

        Trially secures $4.7M seed round, launches ‘Margo’ AI solution to clear patient bottleneck

        By Tommy Felts | September 16, 2025

        A Kansas City startup’s AI-first platform is expected to save time — and patient lives — thanks to a successful seed round for its clinical trial recruitment tech, explained Kyle McAllister, noting his startup’s solution could help speed up access to treatment by years. Trially, one of Startland News’ 10 Kansas City Startups to Watch in…

        She scored music on Netflix and LA’s star-studded stages; now BodaciousThang is getting vulnerable in KC

        By Tommy Felts | September 16, 2025

        When Cheyenne Jolene steps on stage in the shoes of her alter ego, the singer-songwriter’s voice carries both raw emotion and unapologetic truth. Performing as BodaciousThang, Jolene blends R&B, hip hop, rock, and soul into what she describes as “genre bending” music. Her songs are steeped in authenticity and storytelling, offering listeners intimate glimpses into…